David May, MD, PhD, FACC, and Patrick White explain how communication barriers between healthcare professionals and patients, as well as a lack of understanding about patients’ health behaviors following hospital discharge, can lead to unnecessary hospital readmissions, medication errors, and serious health complications.
Mr White discusses the significant costs and decreased quality of care that can result from a lack of oversight by physicians regarding their patients’ health behaviors. He explains that because only one-third of patients follow a physician’s prescription completely, physicians need to improve how they manage their patients.
Dr May discusses the consequences that can result when physicians fail to provide important information to patients and their caregivers to ensure good transitions of care. Unnecessary readmissions are likely to occur when patients or their loved ones do not know what to expect following a hospital discharge.
Dr May concludes that physicians should provide information to their patients during transitions between healthcare settings in order to reduce medication errors, unnecessary testing, health complications, and costs of care.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More